118 related articles for article (PubMed ID: 19450877)
1. Prednisolone exerts late mitogenic and biphasic effects on resistant acute lymphoblastic leukemia cells: Relation to early gene expression.
Lambrou GI; Vlahopoulos S; Papathanasiou C; Papanikolaou M; Karpusas M; Zoumakis E; Tzortzatou-Stathopoulou F
Leuk Res; 2009 Dec; 33(12):1684-95. PubMed ID: 19450877
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity of cortivazol in childhood acute lymphoblastic leukemia.
Styczynski J; Kurylak A; Wysocki M
Anticancer Res; 2005; 25(3B):2253-8. PubMed ID: 16158972
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity and somatic mutations of the glucocorticoid receptor gene are rarely found at relapse in pediatric acute lymphoblastic leukemia but may occur in a subpopulation early in the disease course.
Irving JA; Minto L; Bailey S; Hall AG
Cancer Res; 2005 Nov; 65(21):9712-8. PubMed ID: 16266991
[TBL] [Abstract][Full Text] [Related]
4. Expression of late cell cycle genes and an increased proliferative capacity characterize very early relapse of childhood acute lymphoblastic leukemia.
Kirschner-Schwabe R; Lottaz C; Tödling J; Rhein P; Karawajew L; Eckert C; von Stackelberg A; Ungethüm U; Kostka D; Kulozik AE; Ludwig WD; Henze G; Spang R; Hagemeier C; Seeger K
Clin Cancer Res; 2006 Aug; 12(15):4553-61. PubMed ID: 16899601
[TBL] [Abstract][Full Text] [Related]
5. Circumvention of glucocorticoid resistance in childhood leukemia.
Haarman EG; Kaspers GJ; Pieters R; Rottier MM; Veerman AJ
Leuk Res; 2008 Sep; 32(9):1417-23. PubMed ID: 18395253
[TBL] [Abstract][Full Text] [Related]
6. Genetic alterations determine chemotherapy resistance in childhood T-ALL: modelling in stage-specific cell lines and correlation with diagnostic patient samples.
Estes DA; Lovato DM; Khawaja HM; Winter SS; Larson RS
Br J Haematol; 2007 Oct; 139(1):20-30. PubMed ID: 17854304
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling of leukemia T-cells resistant to methotrexate and 7-hydroxymethotrexate reveals alterations that preserve intracellular levels of folate and nucleotide biosynthesis.
Fotoohi AK; Assaraf YG; Moshfegh A; Hashemi J; Jansen G; Peters GJ; Larsson C; Albertioni F
Biochem Pharmacol; 2009 Apr; 77(8):1410-7. PubMed ID: 19426680
[TBL] [Abstract][Full Text] [Related]
8. Regulatory effect of resveratrol and prednisolone on MDR1 gene expression in acute lymphoblastic leukemia cell line (CCRF-CEM): An epigenetic perspective.
Zadi Heydarabad M; Nikasa M; Vatanmakanian M; Azimi A; Farshdousti Hagh M
J Cell Biochem; 2018 Jun; 119(6):4890-4896. PubMed ID: 29377275
[TBL] [Abstract][Full Text] [Related]
9. Initial leukemic gene expression profiles of patients with poor in vivo prednisone response are similar to those of blasts persisting under prednisone treatment in childhood acute lymphoblastic leukemia.
Cario G; Fetz A; Bretscher C; Möricke A; Schrauder A; Stanulla M; Schrappe M
Ann Hematol; 2008 Sep; 87(9):709-16. PubMed ID: 18521602
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Prednisolone on miR 15a and miR16-1 Expression Levels and Apoptosis in Acute Lymphoblastic Leukemia Cell Line: CCRF-CEM.
Azimi A; Hagh MF; Yousefi B; Rahnama MA; Khorrami A; Heydarabad MZ; Najafpour M; Hallajzadeh J; Ghahremani A
Drug Res (Stuttg); 2016 Aug; 66(8):432-5. PubMed ID: 27281445
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of BAX and BCL-2 Gene Expression and Apoptosis Induction in Acute Lymphoblastic Leukemia Cell Line CCRFCEM after High- Dose Prednisolone Treatment.
Ghasemi A; Khanzadeh T; Zadi Heydarabad M; Khorrami A; Jahanban Esfahlan A; Ghavipanjeh S; Gholipour Belverdi M; Darvishani Fikouhi S; Darbin A; Najafpour M; Azimi A
Asian Pac J Cancer Prev; 2018 Aug; 19(8):2319-2323. PubMed ID: 30141309
[TBL] [Abstract][Full Text] [Related]
12. Ex vivo modulation of response to prednisolone in childhood acute lymphoblastic leukaemia.
Styczynski J; Wysocki M
Br J Haematol; 2006 May; 133(4):397-9. PubMed ID: 16643446
[TBL] [Abstract][Full Text] [Related]
13. Expression of the glucocorticoid receptor and its isoforms in relation to glucocorticoid resistance in childhood acute lymphocytic leukemia.
Tissing WJ; Lauten M; Meijerink JP; den Boer ML; Koper JW; Sonneveld P; Pieters R
Haematologica; 2005 Sep; 90(9):1279-81. PubMed ID: 16154856
[TBL] [Abstract][Full Text] [Related]
14. Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.
Fulci V; Colombo T; Chiaretti S; Messina M; Citarella F; Tavolaro S; Guarini A; Foà R; Macino G
Genes Chromosomes Cancer; 2009 Dec; 48(12):1069-82. PubMed ID: 19760605
[TBL] [Abstract][Full Text] [Related]
15. Dual Mechanisms of Metabolism and Gene Expression of the CCRF-CEM Leukemia Cells under Glucocorticoid Treatment.
Lambrou GI; Karakonstantakis T; Vlahopoulos S; Zaravinos A
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072627
[TBL] [Abstract][Full Text] [Related]
16. Regulatory Effect of Resveratrol and Prednisolone on MDR1 Protein Expression in Acute Lymphoblastic Leukemia Cell Line (CCRF-CEM).
Talebi M; Bahar Aghdam S; Azimi A; Mohammadi H; Karimi Yonjali S; Asariha M; Zadi Heydarabad M
Asian Pac J Cancer Prev; 2019 Apr; 20(4):1171-1176. PubMed ID: 31030491
[TBL] [Abstract][Full Text] [Related]
17. Changes in the MDR1 gene expression after short-term ex vivo therapy with prednisolone have prognostic impact in childhood acute lymphoblastic leukemia.
Janiszewska H; Styczynski J; Kolodziej B; Wysocki M; Haus O
Ann Hematol; 2009 Dec; 88(12):1193-8. PubMed ID: 19352661
[TBL] [Abstract][Full Text] [Related]
18. Alternative medicine remedies might stimulate viability of leukemic cells.
Styczynski J; Wysocki M
Pediatr Blood Cancer; 2006 Jan; 46(1):94-8. PubMed ID: 16047362
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of the in vivo expression of glucocorticoid receptor splice variants during prednisone treatment in childhood acute lymphoblastic leukaemia.
Lauten M; Fernandez-Munoz I; Gerdes K; von Neuhoff N; Welte K; Schlegelberger B; Schrappe M; Beger C
Pediatr Blood Cancer; 2009 Apr; 52(4):459-63. PubMed ID: 19061214
[TBL] [Abstract][Full Text] [Related]
20. Two distinct molecular mechanisms underlying cytarabine resistance in human leukemic cells.
Cai J; Damaraju VL; Groulx N; Mowles D; Peng Y; Robins MJ; Cass CE; Gros P
Cancer Res; 2008 Apr; 68(7):2349-57. PubMed ID: 18381442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
